12/1/99
Total Hits: 2
- [1] fr01de99N Draft Guidance for Industry on Labeling
of Over-the-Counter Human
- Size: 4877 , Score: 681 , TEXT
- [2] fr01de99P Postmarketing Studies for Human Drugs and Licensed Biological
- Size: 65989 , Score: 661 , TEXT
12/2/99
Total Hits: 0
12/3/99
Total Hits: 3
- [1] fr03de99R Prescription Drug Marketing Act of 1987;
Prescription Drug
- Size: 320216 , Score: 1000 , TEXT
- [2] fr03de99N Guidance for Industry on ANDA's: Impurities in Drug Substances;
- Size: 4416 , Score: 707 , TEXT
- [3] fr03de99N Advisory Committees; Filing of Annual Reports
- Size: 2801 , Score: 654 , TEXT
12/6/99
Total Hits: 0
12/7/99
Total Hits: 1
- [1] fr07de99N Draft Guidance for Industry on Pharmacokinetics
in Patients With
- Size: 4700 , Score: 836 , TEXT
12/8/99
Total Hits: 1
- [1] fr08de99N Draft Guidance for Industry on Applications
Covered by Section
- Size: 5654 , Score: 686 , TEXT
12/9/99
Total Hits: 0
12/10/99
Total Hits: 0
12/13/99
Total Hits: 0
12/14/99
Total Hits: 0
12/15/99
Total Hits: 0
12/16/99
Total Hits: 0
12/17/99
Total Hits: 0
12/20/99
Total Hits: 1
- [1] fr20de99P Additional Criteria and Procedures for
Classifying Over-the-
- Size: 144226 , Score: 949 , TEXT
12/21/99
Total Hits: 0
12/22/99
Total Hits: 1
- [1] fr22de99N Draft Guidance for Industry on Disclosing
Information Provided to
- Size: 21331 , Score: 1000 , TEXT
12/23/99
Total Hits: 0
12/24/99
Total Hits: 0
12/27/99
Total Hits: 2
- [1] fr27de99N Withdrawal of Guidance Document on Selegiline
Hydrochloride
- Size: 4459 , Score: 827 , TEXT
- [2] fr27de99N Peripheral and Central Nervous System Drugs Advisory Committee;
- Size: 3044 , Score: 694 , TEXT
12/28/99
Total Hits: 0
12/29/99
Total Hits: 0
12/30/99
Total Hits: 0
12/31/99
Total Hits: 0
 |